Id |
Subject |
Object |
Predicate |
Lexical cue |
T0 |
0-13 |
JJ |
denotes |
Site-specific |
T1 |
14-20 |
NN |
denotes |
glycan |
T2 |
21-29 |
NN |
denotes |
analysis |
T3 |
30-32 |
IN |
denotes |
of |
T4 |
33-36 |
DT |
denotes |
the |
T5 |
37-47 |
NN |
denotes |
SARS-CoV-2 |
T6 |
48-53 |
NN |
denotes |
spike |
T7 |
55-65 |
NN |
denotes |
SARS-CoV-2 |
T8 |
66-71 |
NN |
denotes |
spike |
T9 |
72-79 |
NN |
denotes |
protein |
T10 |
79-80 |
-COMMA- |
denotes |
, |
T11 |
81-91 |
VBD |
denotes |
elaborated |
T12 |
92-99 |
NN |
denotes |
Vaccine |
T13 |
100-111 |
NN |
denotes |
development |
T14 |
112-115 |
IN |
denotes |
for |
T15 |
116-122 |
JJ |
denotes |
severe |
T16 |
123-128 |
JJ |
denotes |
acute |
T17 |
129-140 |
JJ |
denotes |
respiratory |
T18 |
141-149 |
NN |
denotes |
syndrome |
T19 |
150-161 |
NN |
denotes |
coronavirus |
T20 |
162-163 |
CD |
denotes |
2 |
T21 |
164-165 |
-LRB- |
denotes |
( |
T22 |
165-175 |
NN |
denotes |
SARS-CoV-2 |
T23 |
175-176 |
-RRB- |
denotes |
) |
T24 |
177-179 |
VBZ |
denotes |
is |
T25 |
180-187 |
VBN |
denotes |
focused |
T26 |
188-190 |
IN |
denotes |
on |
T27 |
191-194 |
DT |
denotes |
the |
T28 |
195-203 |
JJ |
denotes |
trimeric |
T29 |
204-209 |
NN |
denotes |
spike |
T30 |
210-217 |
NN |
denotes |
protein |
T31 |
218-222 |
WDT |
denotes |
that |
T32 |
223-232 |
VBZ |
denotes |
initiates |
T33 |
233-242 |
NN |
denotes |
infection |
T34 |
244-248 |
DT |
denotes |
Each |
T35 |
249-257 |
NN |
denotes |
protomer |
T36 |
258-260 |
IN |
denotes |
in |
T37 |
261-264 |
DT |
denotes |
the |
T38 |
265-273 |
JJ |
denotes |
trimeric |
T39 |
274-279 |
NN |
denotes |
spike |
T40 |
280-283 |
VBZ |
denotes |
has |
T41 |
284-286 |
CD |
denotes |
22 |
T42 |
287-300 |
NN |
denotes |
glycosylation |
T43 |
301-306 |
NNS |
denotes |
sites |
T44 |
308-311 |
WRB |
denotes |
How |
T45 |
312-317 |
DT |
denotes |
these |
R0 |
T2 |
T0 |
arg1Of |
analysis,Site-specific |
R1 |
T2 |
T1 |
arg1Of |
analysis,glycan |
R10 |
T13 |
T12 |
arg1Of |
development,Vaccine |
R11 |
T13 |
T14 |
arg1Of |
development,for |
R12 |
T19 |
T14 |
arg2Of |
coronavirus,for |
R13 |
T19 |
T15 |
arg1Of |
coronavirus,severe |
R14 |
T19 |
T16 |
arg1Of |
coronavirus,acute |
R15 |
T19 |
T17 |
arg1Of |
coronavirus,respiratory |
R16 |
T19 |
T18 |
arg1Of |
coronavirus,syndrome |
R17 |
T19 |
T20 |
arg1Of |
coronavirus,2 |
R18 |
T19 |
T21 |
arg1Of |
coronavirus,( |
R19 |
T22 |
T21 |
arg2Of |
SARS-CoV-2,( |
R2 |
T2 |
T3 |
arg1Of |
analysis,of |
R20 |
T23 |
T21 |
arg3Of |
),( |
R21 |
T13 |
T24 |
arg1Of |
development,is |
R22 |
T25 |
T24 |
arg2Of |
focused,is |
R23 |
T13 |
T25 |
arg2Of |
development,focused |
R24 |
T25 |
T26 |
arg1Of |
focused,on |
R25 |
T30 |
T26 |
arg2Of |
protein,on |
R26 |
T30 |
T27 |
arg1Of |
protein,the |
R27 |
T30 |
T28 |
arg1Of |
protein,trimeric |
R28 |
T30 |
T29 |
arg1Of |
protein,spike |
R29 |
T30 |
T31 |
arg1Of |
protein,that |
R3 |
T6 |
T3 |
arg2Of |
spike,of |
R30 |
T30 |
T32 |
arg1Of |
protein,initiates |
R31 |
T33 |
T32 |
arg2Of |
infection,initiates |
R32 |
T35 |
T34 |
arg1Of |
protomer,Each |
R33 |
T35 |
T36 |
arg1Of |
protomer,in |
R34 |
T39 |
T36 |
arg2Of |
spike,in |
R35 |
T39 |
T37 |
arg1Of |
spike,the |
R36 |
T39 |
T38 |
arg1Of |
spike,trimeric |
R37 |
T35 |
T40 |
arg1Of |
protomer,has |
R38 |
T43 |
T40 |
arg2Of |
sites,has |
R39 |
T43 |
T41 |
arg1Of |
sites,22 |
R4 |
T6 |
T4 |
arg1Of |
spike,the |
R40 |
T43 |
T42 |
arg1Of |
sites,glycosylation |
R5 |
T6 |
T5 |
arg1Of |
spike,SARS-CoV-2 |
R6 |
T9 |
T7 |
arg1Of |
protein,SARS-CoV-2 |
R7 |
T9 |
T8 |
arg1Of |
protein,spike |
R8 |
T11 |
T10 |
arg1Of |
elaborated,"," |
R9 |
T9 |
T11 |
arg1Of |
protein,elaborated |